NFYA and non-small cell lung carcinoma: Results indicated that ALDH2 promoter activity was significantly enhanced in NSCLC and NSCLC/PTX cells transfected with a plasmid overexpressing NFYA or HNF4A (Fig. 3D; Fig. S4B-C).